Ofloxacin 200mg + Ornidazole 500mg Tablet

Description

Ofjest-MR Tablet is a dual-action antimicrobial formulation designed to offer broad and complementary coverage against a wide range of bacterial and protozoal organisms. This combination brings together a fluoroquinolone antibiotic with a nitroimidazole derivative, creating a synergistic profile that supports clinicians in managing mixed or complex infections where multi-spectrum antimicrobial activity is considered appropriate. Ofloxacin, a well-established fluoroquinolone, acts by inhibiting bacterial DNA gyrase and topoisomerase IV—enzymes essential for bacterial replication, transcription, and repair. This targeted mechanism interferes with the growth and survival of various Gram-positive and Gram-negative bacteria, making Ofloxacin widely recognized for its dependable antibacterial performance. Ornidazole, a nitroimidazole compound, provides potent activity against anaerobic bacteria and protozoa. It works by disrupting DNA structure and synthesis within susceptible microorganisms. Its ability to complement Ofloxacin makes the combination particularly valuable in clinical situations where both aerobic and anaerobic pathogens may be involved. The 200 mg + 500 mg strength pairing is formulated to deliver balanced antimicrobial coverage with consistent absorption and predictable pharmacokinetics. Each tablet is designed for convenient oral administration, offering reliable performance and ease of use. This combination is frequently selected in clinical practice when a healthcare professional identifies the need for dual antimicrobial mechanisms tailored to the patient’s condition. Ofloxacin + Ornidazole Tablets are widely utilized in the management of infections involving the gastrointestinal tract, genitourinary system, and other areas where mixed microbial involvement is suspected, as guided by a healthcare provider’s assessment and local sensitivity patterns. As with all prescription antimicrobial therapies, use should be supervised by a qualified healthcare professional. Responsible administration, adherence to recommended duration, and avoidance of unnecessary usage help ensure both safety and long-term effectiveness while reducing the risk of antimicrobial resistance.